協鑫科技(03800.HK)包頭基地一期首個2萬噸顆粒硅模組正式投產
協鑫科技(03800.HK)公布,包頭基地一期10萬噸首個2萬噸顆粒硅模組已正式投產,配套15萬噸納米硅產能也同時產出合格產品,兩者生產物耗、產品品質均達項目設計水平。
項目達產後,公司顆粒硅產能將達26萬噸。此外,顆粒硅徐州4萬噸置換項目及呼和浩特10萬噸均已進入基建階段,烏海等項目已通過董事會審議。未來三年,公司顆粒硅產能計劃以每年約20萬噸速度新增產能落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.